Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate

Biopharmaceutics and Drug Disposition

Volumn 25, Issue 6, 2004, Pages 273-282

  Lee, Ae K ^a   Lee, Joo H ^a   Kwon, Jong W ^b   Kim, Won B ^b   Kim, Sang G ^a   Kim, So H ^c   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

^c Gangneung Wonju National University   (South Korea)

Author keywords

Clarithromycin; CYP3A1 2; Pharmacokinectics; Rats; Rats with U ARF

Indexed keywords

14 HYDROXYCLARITHROMYCIN; CHLORZOXAZONE; CLARITHROMYCIN; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; DEXAMETHASONE; DRUG METABOLITE; ISOENZYME; ROXITHROMYCIN; THEOPHYLLINE; TROLEANDOMYCIN; URANYL NITRATE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; LIVER HOMOGENATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SUPERNATANT;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ARYL HYDROCARBON HYDROXYLASES; CLARITHROMYCIN; DEXAMETHASONE; ENZYME INDUCTION; HALF-LIFE; INJECTIONS, INTRAVENOUS; ISOENZYMES; KIDNEY FAILURE, ACUTE; MALE; MEMBRANE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TROLEANDOMYCIN; URANYL NITRATE;

EID: 4644329274     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.409     Document Type: Article

References (31)

1. Chung HC, Kim SH, Lee MG, Kim SG. Increase in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): The role of urea in CYP2E1 induction by acute renal failure. Drug Metab Dispos 2002; 30: 739-746.
2. Moon YJ, Lee AK, Chung HC, et al. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats. Drug Metab Dispos 2003; 31: 776-784.
3. Ahn CY, Kim EJ, Lee I, et al. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate. J Pharm Sci 2003; 92: 1604-1613.
4. Chung W-S, Kim EJ, Lee I, Kim SG, Lee MG, Kim SH. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate. Life Sci 2003; 73: 253-263.
5. Yu SY, Chung HC, Kim EJ, et al. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: The role of CYP2E1 induction in 1,3-dimethyluric acid formation. J Pharm Pharmacol 2002; 54: 1687-1692.
6. Rodvold KA. Clinical pharmacokinetics of clarithromycin. Clin Pharmacokinet 1999; 37: 385-398.
7. Fraschini F, Scaglione F, Demartini G. Clarithromycin clinical pharmacokinetics. Clin Pharmacokinet 1993; 25: 189-204.
8. Ahn CY, Kim EJ, Kwon JW, et al. Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition. Life Sci 2003: 73: 1783-1794.
9. Cho MK, Kim YG, Lee MG, Kim SG. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: Complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 1999; 372: 150-158.
10. Lewis DFV. P450 substrate specificity and metabolism. In Cytochromes P450. Structure, Function and Mechanism. Talyor & Francis: Bristol, 1996; 123.
11. Kim SH, Shim HJ, Kim WB, Lee MG. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure. Antimicrob Agents Chemother 1998; 42: 1217-1221.
12. Bae SK, Lee SJ, Kim YH, Kim JW, Kim SG, Lee MG. Effects of acute renal failure on the pharmacokinetics of oltipraz in rats. J Pharm Sci (in press).
13. Litterst CL, Mimnaugh EG, Reagan RL, Gram TE. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species. Drug Metab Dispos 1975; 3: 259-265.
14. Chu SY, Sennello LT, Sonders RC. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. J Chromatogr 1991; 571: 199-208.
15. Wrighton SA, Maurel P, Schuetz EG, Watkins PB, Young B, Guzelian PS. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat livers as the glucocorticoid responsive cytochrome P-450p. Biochemistry 1985; 24: 2171-2178.
16. Ogiso T, Iwaki M, Tanaka H, et al. Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats. Biol Pharm Bull 1999; 22: 191-196.
17. Halpert JR. Multiplicity of steroid-inducible cytochromes P-450 in rat liver microsomes. Arch Biochem Biophys 1988; 263: 59-68.
18. Arlotto MP, Sonderfan AJ, Klaassen CD, Parkinson A. Studies on the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase. Biochem Pharmacol 1987; 36: 3859-3866.
19. Roos PH, Golub-Ciosk B, Kallweit P, Kauczinski D, Hanstein. WG. Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes. Biochem Pharmacol 1993; 45: 2239-2250.
20. Kim SH, Choi YM, Lee MG. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokinet Biopharm 1993; 21: 1-17.
21. Bae SK, Chung W-S, Kim EJ, et al. Pharmacokinetics, blood partition, and protein binding of DA-7867, a new oxazolidinone. Biopharm Drug Dispos 2004; (in press).
22. Boudinot FD, Jusko WJ. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984; 73: 774-780.
23. Øie S, Guentert TW. Comparison of equilibrium time in dialysis experiments using spiked plasma or spiked buffer. J Pharm Sci 1982; 71: 127-128.
24. Chiou WL. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokinet Biopharm 1978; 6: 539-546.
25. Gibaldi M, Perrier D. Pharmacokinetics (2nd edn). Marcel-Dekker: New York, 1982.
26. Chiou WL. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J Pharm Sci 1980; 69: 90-91.
27. Chiou WL. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimens. J Pharm Sci 1979; 68:1067-1069.
28. Eatman FB, Colburn WA, Boxenbaum HG, et al. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J Pharmacokinet Biopharm 1977; 5: 481-494.
29. Davey PG. The pharmacokinetics of clarithromycin and its 14-OH metabolite. J Hosp Infect 1991; 19 (Suppl. A): 29-37.
30. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993; 10: 1093-1095.
31. Mitruka BM, Rawnsley HM. Clinical Biomedical and Hematological Reference Values in Normal Experimental Animals and Normal Humans (2nd edn). Masson Publishing USA Inc.: New York, 1981; 67.